Exendine zur Glucagon Suppression

European patent · EP1658856 · Deleted

Register entry

Publication number
EP1658856
Application number
EP06002683
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 14, 2000
Published
May 24, 2006
Granted
Mar 17, 2010
Deleted
Jan 31, 2011
Reason
Annual fee unpaid
IPC classes
A61K 38/22 (2006.01)
A61K 47/48 (2006.01)
A61P 5/48 (2006.01)
A61P 17/00 (2006.01)
A61P 35/00 (2006.01)
//C07K 14/575 (2006.01)
Priority
US 116380 P 14.01.1999
US 132017 P 30.04.1999
US 175365 P 10.01.2000
Divided from
EP00902415
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 17, 2011

    Deleted, fee unpaid

    Published in Swissreg on 17.08.2011

  2. Mar 17, 2010

    Granted

    Published in Swissreg on 17.03.2010

Parties

Holder

Amylin Pharmaceuticals, Inc.

9360 Towne Centre Drive, San Diego, CA 92121, US

Inventor

Young, Andrew

Rancho Sante Fe, California 92067, US

Gedulin, Bronislava

Del Mar, California, 92014, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.